StonvexLoading…
StonvexStonvexStonvexCore line items from SRZN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.00M | $3.48M | $2.95M | $1.97M |
Operating Income | $-10.46M | $-42.09M | $-29.45M | $-18.57M |
Net Income | $-127.50M | $-242.03M | $-58.87M | $12.78M |
EPS (Diluted) | $-11.65 | $-32.37 | $-8.49 | $0.85 |
Total Assets | $120.71M | $98.73M | $94.05M | $102.70M |
Total Liabilities | $398.86M | $286.49M | $117.56M | $55.58M |
Cash & Equivalents | $106.91M | $89.25M | $81.33M | $90.39M |
Free Cash Flow OCF − CapEx | $-12.62M | $-30.37M | $-24.50M | $-15.44M |
Shares Outstanding | 11.49M | 9.78M | 8.57M | 8.57M |